Page last updated: 2024-08-22

tranylcypromine and Hepatocellular Carcinoma

tranylcypromine has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, NM; Wu, LW; Zhang, C; Zhang, JK; Zhang, ZY; Zhou, DM; Zhu, HJ1

Other Studies

1 other study(ies) available for tranylcypromine and Hepatocellular Carcinoma

ArticleYear
Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells.
    Biochemical and biophysical research communications, 2019, 05-14, Volume: 512, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Demethylases; Humans; Hydrazines; Kaplan-Meier Estimate; Liver Neoplasms; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Pyridines; Serine; Sulfonamides; Tranylcypromine

2019